Your heart valves regulate blood flow but when advanced valve disease causes problems, valve replacement surgery may be necessary. Surgeons look to two trials on new approaches to improve on patient outcomes.
A Cleveland Clinic patient with a slowed heartbeat is the third in the nation to receive the device as part of an international, multicenter clinical trial testing its safety and efficacy for FDA approval.
Some growth plate injuries cause kids’ arm and leg bones to prematurely stop growing. Cleveland Clinic researchers hope to translate test tube findings into the ability to regenerate damaged growth plates in kids’ bodies.
We may be entering a postantibiotic era, where drug-resistant “superbugs” threaten our health and economy. Learn how science is fighting these superbugs.
The discovery of how the carrier of so-called “good” cholesterol becomes dysfunctional represents the first step toward creating new tests and treatments for cardiovascular disease.
An experimental device that had shown promise and raised hopes for controlling stubbornly and dangerously high blood pressure is not effective, a new study involving Cleveland Clinic cardiologists and patients shows.
To find out which breakthroughs are set to reshape healthcare in the coming year, Cleveland Clinic asked 100 of its top experts — people who focus on patient care very day.
3D printing gives surgeons individualized models of the liver to guide their work. Welcome to the age of precise, personalized surgery.
Mechanical heart pumps, or left ventricular assist devices (LVADs), are lifesaving devices for patients with advanced heart failure, but a new study shows that the HeartMate II has higher risk than originally believed.
A patient shares his story about a new minimally invasive thoracic procedure that would not only cure his ailment, but also provide him with a swift and relatively pain-free recovery.